Consensus Centene Corporation

Stocks

CNC

US15135B1017

Managed Healthcare

Market Closed - NYSE 23:03:59 02/09/2026 +03			5-day change	1st Jan Change
67.34 ^USD	+3.23%		+2.86%	+63.65%

08-31	Centene Corporation Announces Chief Information Officer Changes, Effective August 31, 2026	CI
08-25	Alert incorrectly tagged to Community Health Systems withdrawn	RE

Evolution of the Average Target: Centene Corporation

Evolution of the Target Price: Centene Corporation

Changes in Analyst Recommendations: Centene Corporation

92160c18813.6szTfOu7W5kNGGkkwlqhIdSE_ePT2B3I4a06lxAoDaQ.kL_lMpP8NtRddAZhjw7JSbjQhI2qjSSdgp5zwCNFdcGtm7A4jPUBxmFhIA~ab4165176e9f56b327fac6b2a10e71d7

Analysts' recommendations: Centene Corporation

08-11	Argus Research Upgrades Centene to Buy From Hold, $80 Price Target	MT
08-04	JPMorgan Adjusts Price Target on Centene to $67 From $60, Maintains Neutral Rating	MT
08-03	Bernstein Adjusts Centene Price Target to $79 From $68, Maintains Outperform Rating	MT
07-29	Centene's Strong Q2 Beat Overshadowed by Delayed Medicaid Margin Recovery, RBC Says	MT
07-29	UBS Adjusts Price Target on Centene to $70 From $61, Maintains Neutral Rating	MT
07-29	Jefferies & Co Adjusts Centene Price Target to $59 From $48, Maintains Hold Rating	MT
07-29	Truist Lifts Price Target on Centene to $80 From $78, Keeps Buy Rating	MT
07-29	Goldman Sachs Adjusts Centene Price Target to $56 From $40, Maintains Sell Rating	MT
07-29	Morgan Stanley Adjusts Centene Price Target to $66 From $57, Maintains Equal Weight Rating	MT
07-29	Baird Adjusts Centene Price Target to $66 From $46, Maintains Neutral Rating	MT
07-29	Deutsche Bank Adjusts Centene Price Target to $85 From $80, Maintains Buy Rating	MT
07-29	Analyst recommendations: Carmax, Kla Corporation, Nasdaq, Fortinet, PayPal…
07-28	Barclays Raises Centene Price Target to $80 From $75	MT
07-14	Truist Raises Price Target on Centene to $78 From $71, Keeps Buy Rating	MT
07-14	TD Cowen Adjusts Price Target on Centene to $65 From $47, Maintains Hold Rating	MT
07-13	Mizuho Adjusts Price Target on Centene to $69 From $63, Maintains Neutral Rating	MT
07-13	Wells Fargo Adjusts Price Target on Centene to $69 From $56, Maintains Equalweight Rating	MT
07-09	RBC Trims Price Target on Centene to $71 From $70, Maintains Sector Perform Rating	MT
07-07	Cantor Fitzgerald Adjusts Centene Price Target to $75 From $60	MT
06-23	Centene's Multi-Year Recovery Underway, RBC Says	MT
06-23	RBC Initiates Centene at Sector Perform With $70 Price Target	MT
06-08	JPMorgan Adjusts Price Target on Centene to $60 From $52, Maintains Neutral Rating	MT
06-04	UnitedHealth, CVS, Cigna Seen Benefiting From Utilization Trends, AI Upside, Morgan Stanley Says	MT
06-04	Morgan Stanley Raises Price Target on Centene to $57 From $50, Keeps Equalweight Rating	MT
06-04	Morgan Stanley Adjusts Price Target on Centene to $57 From $50, Maintains Equalweight Rating	MT

More recommendations

Other Managed Healthcare

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	CENTENE CORPORATION					+6.43%
	UNITEDHEALTH GROUP INC.					+18.91%
	ELEVANCE HEALTH, INC.					+10.66%
	CIGNA					+20.71%
	HUMANA INC.					+4.4%
	MOLINA HEALTHCARE, INC.					+3.21%
	ALIGNMENT HEALTHCARE, INC.					+77.17%
	CLOVER HEALTH INVESTMENTS, CORP.					+20.16%
	PROGYNY, INC.					+30.28%
	Average					+21.32%
	Weighted average by Cap.					+16.20%